Skip to main content
Erschienen in: Journal of Neurology 9/2013

01.09.2013 | Original Communication

Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure

verfasst von: Susanne Abdulla, Stefan Vielhaber, Sonja Körner, Judith Machts, Hans-Jochen Heinze, Reinhard Dengler, Susanne Petri

Erschienen in: Journal of Neurology | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

The revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) is a well-established rating instrument to assess the functional status of ALS patients. A recent innovation was the addition of three further items designed to improve its sensitivity at lower levels of physical function (ALSFRS-Extension, ALSFRS-EX). Neither the ALSFRS-R nor the ALSFRS-EX has been validated in German yet. The aim of the present study was the validation of the German version of a self-administered form of the ALSFRS-EX. Seventy-six patients participated in the study. Psychometric analysis included reliability assessment and factorial analysis. To evaluate convergent validity, correlations between ALSFRS-EX items and the MRC score, spasticity, tongue movement, pulmonary function, ALSAQ-40 and Borg dyspnoea scales (upright and supine) were performed. Internal consistency as measured by Cronbach’s alpha (total scale 0.868, subscales 0.690–0.938) and corrected item to total correlations (all above 0.50) was high. Test–retest reliability assessed by Spearman’s rho (0.882–0.972) and Cohen’s Kappa (0.63–0.92) was also high. Principal component analysis with varimax rotation yielded a four-factor solution accounting for approximately 79 % of the variance. Clinical parameters were strongly correlated with respective items and subscores of the ALSFRS-EX (muscle strength 0.568–0.833 p < 0.01; spasticity −0.236 to −0.376 p < 0.05; tongue movement 0.437–0.818 p < 0.01; pulmonary function 0.485–0.577 p < 0.01). ALSAQ-40 and Borg score correlated highly with the corresponding ALSFRS-EX items. The German self-report version of the ALSFRS-EX possesses very good psychometric properties similar to the original scale including high internal consistency and test–retest reliability as well as excellent convergent validity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates the assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21PubMedCrossRef Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates the assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21PubMedCrossRef
2.
Zurück zum Zitat Montes J, Levy G, Albert S, Kaufmann P, Buchsbaum R, Gordon PH, Mitsumoto H (2006) Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 67:1294–1296PubMedCrossRef Montes J, Levy G, Albert S, Kaufmann P, Buchsbaum R, Gordon PH, Mitsumoto H (2006) Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 67:1294–1296PubMedCrossRef
3.
Zurück zum Zitat Cedarbaum JM, Stambler N (1997) Performance of the Amyotrophic Lateral Sclerosis Rating Scale (ALSFRS) in multicenter trials. J Neurol Sci 152(Suppl 1):S1–S9PubMedCrossRef Cedarbaum JM, Stambler N (1997) Performance of the Amyotrophic Lateral Sclerosis Rating Scale (ALSFRS) in multicenter trials. J Neurol Sci 152(Suppl 1):S1–S9PubMedCrossRef
4.
Zurück zum Zitat Ohashi Y, Tashiro K, Itoyama Y, Nakano I, Sobue G, Nakamura S, Sumino S, Yanagisawa N (2001) Study of functional rating scale for amytrophic lateral sclerosis: revised ALSFRS (ALSFRS-R) Japanese version. No To Shinkei 53:346–355PubMed Ohashi Y, Tashiro K, Itoyama Y, Nakano I, Sobue G, Nakamura S, Sumino S, Yanagisawa N (2001) Study of functional rating scale for amytrophic lateral sclerosis: revised ALSFRS (ALSFRS-R) Japanese version. No To Shinkei 53:346–355PubMed
5.
Zurück zum Zitat Kim HY, Park KH, Koh SH, Lee SC, Nam YH, Kim J, Kim SH (2007) Korean version of Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised: a pilot study on the reliability and validity. J Korean Neurol Assoc 25:149–154 Kim HY, Park KH, Koh SH, Lee SC, Nam YH, Kim J, Kim SH (2007) Korean version of Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised: a pilot study on the reliability and validity. J Korean Neurol Assoc 25:149–154
6.
Zurück zum Zitat Guedes K, Pereira C, Pavan K, Valério BC (2010) Cross-cultural adaptation and validation of ALS functional rating scale-revised in Portuguese language. Arq Neuropsiquiatr 68:44–47PubMedCrossRef Guedes K, Pereira C, Pavan K, Valério BC (2010) Cross-cultural adaptation and validation of ALS functional rating scale-revised in Portuguese language. Arq Neuropsiquiatr 68:44–47PubMedCrossRef
7.
Zurück zum Zitat Campos TS, Rodríguez-Santos F, Esteban J, Vázquez PC, Mora Paradina JS, Carmona AC (2010) Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Rating Scale (ALSFRS-R). Amyotroph Lateral Scler 11:475–477PubMedCrossRef Campos TS, Rodríguez-Santos F, Esteban J, Vázquez PC, Mora Paradina JS, Carmona AC (2010) Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Rating Scale (ALSFRS-R). Amyotroph Lateral Scler 11:475–477PubMedCrossRef
8.
Zurück zum Zitat Atsuta N, Watanabe H, Ito M, Nakamura R, Senda J, Kato S, Sobue G (2011) Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study. Brain Nerve 63:491–496PubMed Atsuta N, Watanabe H, Ito M, Nakamura R, Senda J, Kato S, Sobue G (2011) Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study. Brain Nerve 63:491–496PubMed
9.
Zurück zum Zitat Kaufmann P, Levy G, Montes J, Buchsbaum R, Barsdorf AI, Battista V, Arbing R, Gordon PH, Mitsumoto H, Levin B, Thompson JL, QALS study group (2007) Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter trial. Amyotroph Lateral Scler 8:42–46PubMedCrossRef Kaufmann P, Levy G, Montes J, Buchsbaum R, Barsdorf AI, Battista V, Arbing R, Gordon PH, Mitsumoto H, Levin B, Thompson JL, QALS study group (2007) Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter trial. Amyotroph Lateral Scler 8:42–46PubMedCrossRef
10.
Zurück zum Zitat Kasarskis EJ, Dempsey Hall L, Thompson MM, Luu LC, Mendiondo M, Kryscio R (2005) Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 6:50–54PubMedCrossRef Kasarskis EJ, Dempsey Hall L, Thompson MM, Luu LC, Mendiondo M, Kryscio R (2005) Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 6:50–54PubMedCrossRef
11.
Zurück zum Zitat Miano B, Stoddard GJ, Davis S, Bromberg MB (2004) Inter-evaluator reliability of the ALS functional rating scale. Amyotroph Lateral Scler Other Motor Neuron Disord 5:235–239PubMedCrossRef Miano B, Stoddard GJ, Davis S, Bromberg MB (2004) Inter-evaluator reliability of the ALS functional rating scale. Amyotroph Lateral Scler Other Motor Neuron Disord 5:235–239PubMedCrossRef
12.
Zurück zum Zitat Mannino M, Cellura E, Grimaldi G, Volanti P, Piccoli F, La Bella V (2007) Telephone follow-up for patients with amyotrophic lateral sclerosis. Eur J Neurol 14:79–84PubMedCrossRef Mannino M, Cellura E, Grimaldi G, Volanti P, Piccoli F, La Bella V (2007) Telephone follow-up for patients with amyotrophic lateral sclerosis. Eur J Neurol 14:79–84PubMedCrossRef
13.
Zurück zum Zitat Maier A, Holm T, Wicks P, Steinfurth L, Linke P, Münch C, Meyer R, Meyer T (2012) Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial. Amyotroph Lateral Scler 13:210–216PubMedCrossRef Maier A, Holm T, Wicks P, Steinfurth L, Linke P, Münch C, Meyer R, Meyer T (2012) Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial. Amyotroph Lateral Scler 13:210–216PubMedCrossRef
14.
Zurück zum Zitat Wicks P, Massagli MP, Wolf C, Heywood J (2009) Measuring function in advanced ALS: validation of ALSFRS-EX extension items. Eur J Neurol 16:353–359PubMedCrossRef Wicks P, Massagli MP, Wolf C, Heywood J (2009) Measuring function in advanced ALS: validation of ALSFRS-EX extension items. Eur J Neurol 16:353–359PubMedCrossRef
15.
Zurück zum Zitat Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disorder 1:293–299CrossRef Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disorder 1:293–299CrossRef
16.
Zurück zum Zitat Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Wijesekera L, Turner MR, Leigh PN, Shaw CE, Al-Chalabi A (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135:847–852PubMedCrossRef Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Wijesekera L, Turner MR, Leigh PN, Shaw CE, Al-Chalabi A (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135:847–852PubMedCrossRef
17.
Zurück zum Zitat Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, Talbot K, Al-Chalabi A (2011) Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:853–854PubMedCrossRef Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, Talbot K, Al-Chalabi A (2011) Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:853–854PubMedCrossRef
18.
Zurück zum Zitat Bohannon RW, Smith MB (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67:206–207PubMed Bohannon RW, Smith MB (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67:206–207PubMed
19.
Zurück zum Zitat Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M (1999) Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. J Neurol 246 Suppl 3:III16-21 Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M (1999) Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. J Neurol 246 Suppl 3:III16-21
20.
Zurück zum Zitat Just N, Bautin N, Danel-Brunaud V, Debroucker V, Matran R, Perez T (2010) The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J 35:353–360PubMedCrossRef Just N, Bautin N, Danel-Brunaud V, Debroucker V, Matran R, Perez T (2010) The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J 35:353–360PubMedCrossRef
21.
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioural sciences. Lawrence Erlbaum Associates, Hillsdale Cohen J (1988) Statistical power analysis for the behavioural sciences. Lawrence Erlbaum Associates, Hillsdale
22.
Zurück zum Zitat Ellis CM, Simmons A, Jones DK, Bland J, Dawson JM, Horsfield MA, Williams SC, Leigh PN (1999) Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 53:1051–1058PubMedCrossRef Ellis CM, Simmons A, Jones DK, Bland J, Dawson JM, Horsfield MA, Williams SC, Leigh PN (1999) Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 53:1051–1058PubMedCrossRef
23.
Zurück zum Zitat Streiner DL, Norman GR (2003) Health measurement scales, 3rd edn. Oxford University Press, Oxford Streiner DL, Norman GR (2003) Health measurement scales, 3rd edn. Oxford University Press, Oxford
24.
Zurück zum Zitat Franchignoni F, Mora G, Giordano A, Volanti P, Chiò A (2013) Evidence of multidimensionality in the ALSFRS-R scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry Epub ahead of print 2013 doi:10.1136/jnnp-2012-304701 Franchignoni F, Mora G, Giordano A, Volanti P, Chiò A (2013) Evidence of multidimensionality in the ALSFRS-R scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry Epub ahead of print 2013 doi:10.​1136/​jnnp-2012-304701
25.
Zurück zum Zitat Voustianiouk A, Seidel G, Panchal J, Sivak M, Czaplinski A, Yen A, Appel SH, Lange DJ (2008) ALSFRS and Appel ALS scores: discordance with disease progression. Muscle Nerve 37:668–672PubMedCrossRef Voustianiouk A, Seidel G, Panchal J, Sivak M, Czaplinski A, Yen A, Appel SH, Lange DJ (2008) ALSFRS and Appel ALS scores: discordance with disease progression. Muscle Nerve 37:668–672PubMedCrossRef
26.
Zurück zum Zitat Haverkamp LJ, Appel V, Appel SH (1995) Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 11:707–719CrossRef Haverkamp LJ, Appel V, Appel SH (1995) Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 11:707–719CrossRef
27.
Zurück zum Zitat Shoesmith CL, Findlater K, Rowe A (2007) Strong MJ (2007) Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 78:629–631PubMedCrossRef Shoesmith CL, Findlater K, Rowe A (2007) Strong MJ (2007) Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 78:629–631PubMedCrossRef
28.
Zurück zum Zitat Tanaka Y, Yoshikura N, Harada N, Yamada M, Koumura A, Sakurai T, Hayashi Y, Kimura A, Hozumi I, Inuzuka T (2012) Late-onset patients with sporadic amyotrophic lateral sclerosis in Japan have a higher progression rate of ALSFRS-R at the time of diagnosis. Intern Med 51:579–584PubMedCrossRef Tanaka Y, Yoshikura N, Harada N, Yamada M, Koumura A, Sakurai T, Hayashi Y, Kimura A, Hozumi I, Inuzuka T (2012) Late-onset patients with sporadic amyotrophic lateral sclerosis in Japan have a higher progression rate of ALSFRS-R at the time of diagnosis. Intern Med 51:579–584PubMedCrossRef
29.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
30.
Zurück zum Zitat Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601–609PubMedCrossRef Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601–609PubMedCrossRef
31.
Zurück zum Zitat Menke RA, Abraham I, Thiel CS, Filippini N, Knight S, Talbot K, Turner MR (2012) Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Arch Neurol 69:1493–1499PubMedCrossRef Menke RA, Abraham I, Thiel CS, Filippini N, Knight S, Talbot K, Turner MR (2012) Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Arch Neurol 69:1493–1499PubMedCrossRef
32.
Zurück zum Zitat Iwata NK, Kwan JY, Danielian LE, Butman JA, Tovar-Moll F, Bayat E, Floeter MK (2011) White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 134:2642–2655PubMedCrossRef Iwata NK, Kwan JY, Danielian LE, Butman JA, Tovar-Moll F, Bayat E, Floeter MK (2011) White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 134:2642–2655PubMedCrossRef
33.
Zurück zum Zitat Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR (2010) Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 75:1645–1652PubMedCrossRef Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR (2010) Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 75:1645–1652PubMedCrossRef
Metadaten
Titel
Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure
verfasst von
Susanne Abdulla
Stefan Vielhaber
Sonja Körner
Judith Machts
Hans-Jochen Heinze
Reinhard Dengler
Susanne Petri
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 9/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-6955-6

Weitere Artikel der Ausgabe 9/2013

Journal of Neurology 9/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.